Elevated cerebrospinal fluid and plasma homocysteine levels in ALS

European Journal of Neurology

Volumn 17, Issue 1, 2010, Pages 84-89

  Valentino, F ^a   Bivona, G ^a   Butera, D ^a   Paladino, P ^a   Fazzari, M ^a   Piccoli, T ^a   Ciaccio, M ^a   La Bella, V ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Homocysteine; Plasma

Indexed keywords

BIOCHEMICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLUOROMETER; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; COMORBIDITY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 73449121943     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02752.x     Document Type: Article

References (32)

1. Pezzini A, Del Zotto E, Padovani A. Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr Med Chem 2007 14 : 249 263.
2. Humphrey LL, Fu R, Rogers K, et al. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008 83 : 1203 1212.
3. Tchantchou F, Shea TB. Folate deprivation, the methionine cycle, and Alzheimer's disease. Vitam Horm 2008 79 : 83 97.
4. Postuma RB, Lang AE. Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology 2004 63 : 886 891.
5. Lipton SA, Kim W-K, Choi Y-B, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci U S A 1997 94 : 5923 5928.
6. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003 26 : 137 146.
7. Zieminska E, Matyja E, Kozlowska H, et al. Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem Intl 2006 48 : 491 497.
8. Appel SH, Beers D, Siklos L, et al. Calcium: the darth vader of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001 2 (suppl 1 S47 S54.
9. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004 27 : 723 749.
10. Sung JJ, Kim HJ, Choi-Kwon S, et al. Homocysteine incduces oxidative cytotoxicity in Cu, Zn-superoxide dismutase mutant motor neuronal cell. Neuroreport 2002 13 : 377 381.
11. G93A transgenic mice. Neuropharmacology 2008 54 : 1112 1119.
12. Zoccolella S, Simone IL, Lamberti P, et al. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology 2008 70 : 222 225.
13. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000 1 : 293 299.
14. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987 22 : 328 333.
15. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulphuration of homocysteine. Am J Clin Nutr 1992 55 : 131 138.
16. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol 2000 57 : 1422 1428.
17. Klancnik JM, Cuenod M, Gahwiler BH, et al. Release of endogenous amino acids, including homocysteic and cysteine sulphinic acid, from rat hippocampal slices evoked by electrical stimulation of Schaffer collateral-commissural fibers. Neuroscience 1992 49 : 557 570.
18. Adalbert R, Engelhardt JI, Siklos L. dl-homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathol 2002 103 : 428 436.
19. Chung YH, Hong JJ, Shin CM, et al. Immunohistochemical study on the distribution of homocysteine in the central nervous system of transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res 2003 967 : 226 234.
20. Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors 2009 35 : 120 129.
21. Maeda M, Yamamoto I, Fujio Y, Azuma J. Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta 2003 1623 : 41 46.
22. Roybal CN, Yang S, Sun C-W, et al. Homocysteine increasesthe expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 2004 279 : 14844 14852.
23. Bogaert E, Van Damme P, Poesen K, et al. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging 2009, doi:10.1016/J.neurobiolaging.2008.12.007.
24. Wang Y, Mao XO, Xie L, et al. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 2007 27 : 304 307.
25. Ramsaransing GSM, Fokkema MR, Teelken A, et al. Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006 77 : 189 192.
26. Seshadri S, Beiser A, Selhus J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002 346 : 476 483. (Pubitemid 34441738)
27. Kruse T, Reiber H, Neuhoff V. Amino acid transport across the human blood-CSF barrier An evaluation graph for amino acid concentrations in cerebrospinal fluid. J Neurol Sci 1985 70 : 129 138.
28. Stanger O, Herrmann W, Pietrzik K, et al. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society) Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003 41 : 1392 1403. (Pubitemid 37493551)
29. Yasui K, Kowa H, Nakaso K, et al. Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 2000 55 : 437 440.
30. Sengun IS, Appel SH. Serum anti-FAS antibody levels in amyotrophic lateral sclerosis. J Neuroimmunol 2003 142 : 137 140.
31. Brettschneider J, Petzold A, Süssmuth SD, et al. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 2000 66 : 852 856.
32. Spreux-Varoquaux O, Bensimon G, Lacomblez I, et al. Glutamate levels in amyotrophic lateral sclerosis : a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 2002 193 : 73 78.